Journal of Market Access & Health Policy, Volume 6, Issue 1 (2018)

Browse this journal
Sample our Politics & International Relations journals, sign in here to start your FREE access for 14 days

Journal of Market Access & Health Policy, Volume 6, Issue 1 (2018)

See all volumes and issues
Vol 11, 2023 Vol 10, 2022 Vol 9, 2021 Vol 8, 2020 Vol 7, 2019 Volume 6, 2018 Vol 5, 2017 Vol 4, 2016 Vol 3, 2015 Vol 2, 2014 Vol 1, 2013
Download citations Download PDFs Download issue

Original Research Article

Article
Sales promotion by wholesalers affects general practitioners’ prescription behaviours in Japan
Hirohisa Shimura
Article: 1424474
Published online: 18 Jan 2018
AbstractforSales promotion by wholesalers affects general practitioners’ prescription behaviours in Japan | Full Text | References | PDF (785.9 KB)
  • 1381 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart & Mondher Toumi
Article: 1433426
Published online: 12 Feb 2018
AbstractforLow rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration | Full Text | References | PDF (758.8 KB)
  • 1041 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK
Zalmai Hakimi, Con Kelleher, Samuel Aballéa, Khaled Maman, Jameel Nazir, Colette Mankowski & Isaac Odeyemi
Article: 1438721
Published online: 20 Mar 2018
AbstractforCost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK | Full Text | References | PDF (1.2 MB) | Supplemental
  • 903 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Assessment and diffusion of medical innovations in France: an overview
Amélie Dubromel, Loïc Geffroy, Gilles Aulagner & Claude Dussart
Article: 1458575
Published online: 04 Apr 2018
AbstractforAssessment and diffusion of medical innovations in France: an overview | Full Text | References | PDF (1 MB)
  • 2568 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Approaches to manage ‘affordability’ of high budget impact medicines in key EU countries
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham, Lars-Ake Levin, Maarten J. Postma & Nicolas Touchot
Article: 1478539
Published online: 08 Jun 2018
AbstractforApproaches to manage ‘affordability’ of high budget impact medicines in key EU countries | Full Text | References | PDF (875.2 KB)
  • 2908 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access

Original Research Article

Article
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
Emilie Clay, Aurélien Jamotte, Peter Verhamme, Alexander T. Cohen, Ben. A. Van Hout & Pearl. Gumbs
Article: 1495974
Published online: 17 Jul 2018
AbstractforCost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK | Full Text | References | PDF (1.4 MB)
  • 1870 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease
Jesper Jørgensen, Spiros Servos & Panos Kefalas
Article: 1500419
Published online: 06 Aug 2018
AbstractforThe potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease | Full Text | References | PDF (1.6 MB)
  • 2183 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Systematic review of pharmacoeconomic models for schizophrenia
Junwen Zhou, Aurélie Millier & Mondher Toumi
Article: 1508272
Published online: 14 Aug 2018
AbstractforSystematic review of pharmacoeconomic models for schizophrenia | Full Text | References | PDF (1,010.3 KB) | Supplemental
  • 2026 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Original Research Article

Article
Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy
Panos Kefalas, Omar Ali, Jesper Jørgensen, Nick Merryfield, Tim Richardson, Adam Meads, Laura Mungapen & Matthew Durdy
Article: 1511679
Published online: 20 Aug 2018
AbstractforEstablishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy | Full Text | References | PDF (809.3 KB)
  • 1855 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Health related quality of life in patients having schizophrenia negative symptoms – a systematic review
Chiraz Azaiez, Aurélie Millier, Christophe Lançon, Emilie Clay, Pascal Auquier, Pierre-Michel Llorca & Mondher Toumi
Article: 1517573
Published online: 27 Sep 2018
AbstractforHealth related quality of life in patients having schizophrenia negative symptoms – a systematic review | Full Text | References | PDF (1.5 MB) | Supplemental
  • 1529 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Original Research Article

Article
Budget impact of antimicrobial wound dressings in the treatment of venous leg ulcers in the German outpatient care sector: a budget impact analysis
Maria Gueltzow, Poroshat Khalilpour, Katharina Kolbe & York Zoellner
Article: 1527654
Published online: 01 Nov 2018
AbstractforBudget impact of antimicrobial wound dressings in the treatment of venous leg ulcers in the German outpatient care sector: a budget impact analysis | Full Text | References | PDF (1 MB)
  • 1825 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Article
Patient-reported outcome claims in European and United States orphan drug approvals
Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart & Mondher Toumi
Article: 1542920
Published online: 07 Nov 2018
AbstractforPatient-reported outcome claims in European and United States orphan drug approvals | Full Text | References | PDF (817.3 KB)
  • 1446 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Discounting health gain: a different view
Baudouin Standaert et al.
Article | Published online: 2 Nov 2023
Open Access
Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France – the POP study
A. P. Villani et al.
Article | Published online: 1 Nov 2023
Open Access
Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey
Ahmet Fuat et al.
Article | Published online: 29 Oct 2023
Open Access
Women and children’s real-world economic and drug indicators from 2015 to 2019
Jun Zou et al.
Article | Published online: 26 Oct 2023
Open Access